FDA grants emergency use authorization for PHASE Scientific International’s new OTC Indicaid COVID-19 single-use rapid flow immunoassay antigen at-home test; test provides results in about 20 minutes

Sample article from our Tissue & Hygiene

March 22, 2022 (press release) –

The Food and Drug Administration last week authorized for emergency use a new over-the-counter COVID-19 test. The INDICAID COVID-19 Rapid Antigen At-Home Test provides results in about 20 minutes. For more on the test, see the fact sheet for health care providers.



* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.